Gottlieb vs Azar vs Califf vs Gottlieb: The Public Fight Over How The US FDA Should Operate

Yes, Gottlieb’s in there twice; things get complicated when an agency starts to lose credibility.

Alex Azar, Trump’s HHS secretary nominee, who spoke at the Senate HELP committee 11/29/17
HHS Secretary Alex Azar

The US Department of Health and Human Services – the overseer of the Food and Drug Administration and 27 other agencies and offices – is pushing back on suggestions that HHS secretary Alex Azar’s recent move to exert control over regulations was a power play aimed at the FDA.

The effort is part of a larger struggle over FDA’s reputation, with former commissioner Scott Gottlieb playing multiple roles in the drama, including penning a

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA

More from Agency Leadership